Radiation and immune checkpoint inhibitors in the treatment of oligometastatic non-small-cell lung cancer: a practical review of rationale, recent data, and research questions

The combined use of stereotactic ablative radiotherapy (SABR) and immune checkpoint inhibitors (ICIs) is an emerging treatment paradigm for oligometastatic non-small-cell lung cancer (NSCLC). Recent phase I and II trial data suggest that SABR to multiple metastases in addition to ICI use is safe and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zayed, Sondos, Louie, Alexander V., Breadner, Daniel A., Palma, David A., Correa, Rohann J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Controversies in Immunotherapy for Patients with Lung Cancer: Pragmatic Solutions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331344/
https://www.ncbi.nlm.nih.gov/pubmed/37435562
http://dx.doi.org/10.1177/17588359231183668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331344/
https://www.ncbi.nlm.nih.gov/pubmed/37435562
http://dx.doi.org/10.1177/17588359231183668

Ejemplares similares